ARTES and Bio Farma have entered a collaboration for the development and manufacture of vaccine candidates. ARTES will apply its specialized cell line and process development and VLP based vaccine technology, Metavax, and Bio Farma will provide manufacturing of vaccines for the domestic Indonesian markets.   “We are extremely delighted about the mutually agreed collaboration. Bio Farma is a strong and reliable pharmaceutical partner and the only vaccine and antisera producer for humans in Indone...